O. Jarrett

1.5k total citations
38 papers, 1.2k citations indexed

About

O. Jarrett is a scholar working on Genetics, Epidemiology and Virology. According to data from OpenAlex, O. Jarrett has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 18 papers in Epidemiology and 16 papers in Virology. Recurrent topics in O. Jarrett's work include Virus-based gene therapy research (28 papers), HIV Research and Treatment (16 papers) and Herpesvirus Infections and Treatments (9 papers). O. Jarrett is often cited by papers focused on Virus-based gene therapy research (28 papers), HIV Research and Treatment (16 papers) and Herpesvirus Infections and Treatments (9 papers). O. Jarrett collaborates with scholars based in United Kingdom, Netherlands and Australia. O. Jarrett's co-authors include Diane Addie, Margaret J. Hosie, Catherine C. Robertson, John J. Callanan, A. Pacitti, Bruce R. Madewell, Matthew Golder, David M. Hay, Catherine E. Lawrence and Chris K. Grant and has published in prestigious journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Journal of Virology.

In The Last Decade

O. Jarrett

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Jarrett United Kingdom 21 700 599 596 243 200 38 1.2k
Chris K. Grant United States 20 464 0.7× 601 1.0× 450 0.8× 369 1.5× 99 0.5× 57 1.2k
M Bendinelli Italy 21 529 0.8× 790 1.3× 1.0k 1.7× 318 1.3× 151 0.8× 101 1.7k
Helen M. Laird United Kingdom 19 614 0.9× 245 0.4× 484 0.8× 413 1.7× 175 0.9× 38 1.3k
G. H. Theilen United States 19 836 1.2× 282 0.5× 413 0.7× 458 1.9× 260 1.3× 60 1.6k
Christopher D. Ackley United States 11 428 0.6× 759 1.3× 708 1.2× 180 0.7× 41 0.2× 13 987
Gordon H. Theilen United States 18 497 0.7× 188 0.3× 350 0.6× 264 1.1× 129 0.6× 35 1.1k
A. H. Sliski United States 15 392 0.6× 414 0.7× 371 0.6× 834 3.4× 127 0.6× 20 1.5k
B. O'Neil United Kingdom 20 380 0.5× 184 0.3× 952 1.6× 556 2.3× 131 0.7× 27 1.5k
Drew L. Lichtenstein United States 16 831 1.2× 214 0.4× 439 0.7× 210 0.9× 161 0.8× 23 1.3k
Fernando de Noronha United States 14 274 0.4× 217 0.4× 288 0.5× 211 0.9× 92 0.5× 33 737

Countries citing papers authored by O. Jarrett

Since Specialization
Citations

This map shows the geographic impact of O. Jarrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Jarrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Jarrett more than expected).

Fields of papers citing papers by O. Jarrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Jarrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Jarrett. The network helps show where O. Jarrett may publish in the future.

Co-authorship network of co-authors of O. Jarrett

This figure shows the co-authorship network connecting the top 25 collaborators of O. Jarrett. A scholar is included among the top collaborators of O. Jarrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Jarrett. O. Jarrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flynn, J. Norman, Linda Hanlon, & O. Jarrett. (2000). Feline leukaemia virus: protective immunity is mediated by virus‐specific cytotoxic T lymphocytes. Immunology. 101(1). 120–125. 51 indexed citations
2.
Flynn, J. Norman, Celia Cannon, Nancy MacKay, et al.. (1998). DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies (vol 72, pg 7310, 1998). Journal of Virology. 72(10). 8460–8460. 2 indexed citations
3.
Beatty, Julia A., Catherine E. Lawrence, John J. Callanan, et al.. (1998). Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis. Veterinary Immunology and Immunopathology. 65(2-4). 309–322. 30 indexed citations
4.
Murray, Gordon, et al.. (1995). The risk of typical and antibody enhanced feline infectious peritonitis among cats from feline coronavirus endemic households. 23(3). 24–26. 12 indexed citations
5.
Spalding, Judson W. & O. Jarrett. (1995). Feline immunology and immunodeficiency. Oxford University Press eBooks. 31 indexed citations
6.
Terry, Anne, John J. Callanan, Ruth Fulton, O. Jarrett, & James C. Neil. (1995). Molecular analysis of tumours from feline immunodeficiency virus (FIV)‐infected cats: An indirect role for FIV?. International Journal of Cancer. 61(2). 227–232. 33 indexed citations
7.
Callanan, John J., H. Thompson, B. O'Neil, et al.. (1992). Clinical and pathological findings in feline immunodeficiency virus experimental infection. Veterinary Immunology and Immunopathology. 35(1-2). 3–13. 64 indexed citations
8.
Addie, Diane & O. Jarrett. (1992). A study of naturally occurring feline coronavirus infections in kittens. Veterinary Record. 130(7). 133–137. 128 indexed citations
9.
Callanan, John J., et al.. (1992). Lymphosarcoma in experimentally induced feline immunodeficiency virus infection [corrected]. Veterinary Record. 130(14). 293–295. 34 indexed citations
10.
Lawrence, Catherine E., John J. Callanan, & O. Jarrett. (1992). Decreased mitogen responsiveness and elevated tumor necrosis factor production in cats shortly after feline immunodeficiency virus infection. Veterinary Immunology and Immunopathology. 35(1-2). 51–59. 23 indexed citations
11.
Boid, R., et al.. (1991). Isolation of FeLV from a wild felid (Felis silvestris). Veterinary Record. 128(11). 256–256. 9 indexed citations
12.
Callanan, John J., Margaret J. Hosie, & O. Jarrett. (1991). Transmission of feline immunodeficiency virus from mother to kitten. Veterinary Record. 128(14). 332–333. 28 indexed citations
13.
Hosie, Margaret J. & O. Jarrett. (1990). Serological responses of cats to feline immunodeficiency virus. AIDS. 4(3). 215–220. 82 indexed citations
14.
Robertson, Catherine C., et al.. (1989). Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Veterinary Record. 125(11). 293–297. 134 indexed citations
15.
Osterhaus, Albert, et al.. (1987). Comparison of serological responses in cats vaccinated with two different FeLV vaccine preparations. Veterinary Record. 121(11). 260–260. 9 indexed citations
16.
Mochizuki, Manabu & O. Jarrett. (1985). Haemadsorption and Haemagglutination by Feline Leukaemia Viruses. Journal of General Virology. 66(2). 385–389. 2 indexed citations
17.
Jarrett, O., et al.. (1984). Feline leukaemia virus-free lymphosarcoma in a specific pathogen free cat. Veterinary Record. 115(10). 249–250. 7 indexed citations
18.
Suda, Toshio, Nydia G. Testa, T. D. Allen, David Onions, & O. Jarrett. (1983). Effect of hydrocortisone on osteoclasts generated in cat bone marrow cultures. Calcified Tissue International. 35(1). 82–86. 35 indexed citations
19.
Madewell, Bruce R. & O. Jarrett. (1983). Recovery of feline leukaemia virus from non-viraemic cats. Veterinary Record. 112(15). 339–342. 53 indexed citations
20.
Jarrett, O., David M. Hay, & Helen M. Laird. (1974). Infection by feline syncytium-forming virus in Britain. Veterinary Record. 94(10). 200–201. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris K. Grant Breakdown of academic impact, for papers by M Bendinelli Breakdown of academic impact, for papers by Helen M. Laird Breakdown of academic impact, for papers by G. H. Theilen Breakdown of academic impact, for papers by Christopher D. Ackley Breakdown of academic impact, for papers by Gordon H. Theilen Breakdown of academic impact, for papers by A. H. Sliski Breakdown of academic impact, for papers by B. O'Neil Breakdown of academic impact, for papers by Drew L. Lichtenstein Breakdown of academic impact, for papers by Fernando de Noronha
Rankless by CCL
2026